GlassScriptPhysician profile
Dwayne D Montie
NPI 1194946293
$2,429.68
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $626 · 2021: $643.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $864.15 | 2019-2021 | |
| Janssen Biotech, INC. | $386.26 | 2019-2021 | |
| Abbvie INC. | $346.52 | 2019-2021 | |
| Pfizer INC. | $197.45 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $171.04 | 2019-2021 | |
| Lilly USA, LLC | $103.97 | 2019-2021 | |
| Ucb, INC. | $86.83 | 2019-2021 | |
| Genzyme Corporation | $55.49 | 2019-2020 | |
| Amgen INC. | $53.23 | 2019-2020 | |
| Leo Pharma INC. | $28.66 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $23.24 | 2019 | |
| Celgene Corporation | $23.05 | 2019 | |
| Janssen Scientific Affairs, LLC | $19.71 | 2019 | |
| Dusa Pharmaceuticals, INC. | $17.44 | 2019 | |
| Pierre Fabre Pharmaceuticals, INC. | $16.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.82 | 2019 | |
| Sun Pharmaceutical Industries INC. | $15.62 | 2019 | |
| Amniox Medical, INC. | $4.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Montie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.